CAAP Rule and Prescription Drug PricesByBryan S. Walsh, JD,Aaron S. Kesselheim, MD, JD, MPHMarch 18th 2021This article describes a recently finalized CMS rule addressing the permissibility of co-pay accumulator adjustment programs (CAAPs) when no generic is available.